Navigation Links
Halleland Health Consulting Hires New Director of Lifescience Business Development Peter T. Bianco
Date:5/1/2008

Bianco's strategic business experience brings depth to specialized

consulting group

MINNEAPOLIS, May 1 /PRNewswire/ -- Halleland Health Consulting, a wholly owned subsidiary of Minneapolis law firm Halleland Lewis Nilan & Johnson, P.A., announces the hire of Peter T. Bianco as Director of Lifescience Business Development. In addition to coaching bioscience businesses through start-up and growth challenges with the consulting subsidiary, Bianco's work will also be integrated with the law firm's health care and business practice areas.

"Bianco's expertise around medical technologies, services, and infrastructure make him an exceptional addition to our accomplished health consulting team," said Brian Johnson, president of Halleland Lewis Nilan & Johnson. "His strategic and hands-on experience in the bioscience industry brings another level of clarity and competency to our clients."

Bianco comes to the firm after serving as the president of Bioscience Business Development, LLC, where he provided strategic business development for early-stage and large businesses focused on a variety of medical technologies and related services with specific focus on successful early stage lifescience technology commercialization and the financial and physical infrastructure to support it.

Prior to that, he served as the chief executive officer of University Enterprise Laboratories in St. Paul, Minn. His previous experience also includes over ten years in Orthopedic product management, product development engineering and medical device marketing for medical device giant Johnson & Johnson Professional, Inc. and Dow Corning Wright. He began his career in Orthopedic Biomechanics Research at the Mayo Clinic in Rochester, Minn. and Hennepin County Medical Center in Minneapolis, Minn.

He is a founder and board member of Suffolk University's Center for Innovation and Change Leadership (CICL) in Boston, Mass. where he earned his MBA. He received his bachelor's degree in physiology from the University of Minnesota. He serves as vice chairman of the board of directors for the Midwest Orthopedic Research Foundation (MORF) and is a member of the business advisory board for the Regulatory and Clinical Research Institute (RCRI) and Orthopedic Research Society (ORS). Peter currently resides in St. Paul, Minn. with his family.

About Halleland Health Consulting

Halleland Health Consulting, a wholly owned subsidiary of Halleland Lewis Nilan & Johnson, P.A., brings experienced health care professionals with operational, policy and business expertise together with attorneys who specialize in an array of health care and regulatory issues. The integrated team of attorneys, health care providers, public health professionals and health care operations and policy experts helps to guide clients through the maze of legal and business complexities, yielding fresh solutions to contemporary health care problems. Founded in 1996, Halleland Lewis Nilan & Johnson has built its reputation by putting clients first and building a practice centered on values - thus defining the next generation of law firm. In addition to health care, the firm has practice areas in business law and intellectual property litigation, commercial litigation, labor and employment and product liability/mass tort litigation.


'/>"/>
SOURCE Halleland Health Consulting
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Halleland Health Consulting Assists PBMs in Achieving URAC Accreditation for Pharmacy Benefit Management
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: